Search

Hazelnut oil cake (HOC) has the potential to be bioactive component source. Therefore, HOC was processed with a solid-state fermentation (SSF) by Aspergillus oryzae with two steps optimization: Plackett–Burman and Box–Behnken design. The variables were the initial moisture content (X1: 30–50%), incubation temperature (X2: 26–37 °C), and time (X3: 3–5 days), and the response was total peptide content (TPC). The fermented HOC (FHOC) was darker with higher protein, oil, and ash but lower carbohydrate content than HOC. The FHOC had 6.1% more essential amino acid and benzaldehyde comprised 48.8% of determined volatile compounds. Fermentation provided 14 times higher TPC (462.37 mg tryptone/g) and higher phenolic content as 3.5, 48, and 7 times in aqueous, methanolic, and 80% aqueous methanolic extract in FHOC, respectively. FHOC showed higher antioxidant as ABTS+ (75.61 µmol Trolox/g), DPPH (14.09 µmol Trolox/g), and OH (265 mg ascorbic acid/g) radical scavenging, and α-glucosidase inhibition, whereas HOC had more angiotensin converting enzyme inhibition. HOC showed better water absorption while FHOC had better oil absorption activity. Both cakes had similar foaming and emulsifying activity; however, FHOC produced more stable foams and emulsions. SSF at lab-scale yielded more bioactive component with better functionality in FHOC. [ABSTRACT FROM AUTHOR]

Withania somnifera (L.) Dunal is a medicinal plant belonging to the traditional Indian medical system, showing various therapeutic effects such as anti-cancer, anti-inflammatory, anti-microbial, anti-diabetic, and hepatoprotective activity. Of great interest is W. somnifera's potential beneficial effect against neurodegenerative diseases, since the authorized medicinal treatments can only delay disease progression and provide symptomatic relief and are not without side effects. A systematic search of PubMed and Scopus databases was performed to identify preclinical and clinical studies focusing on the applications of W. somnifera in preventing neurodegenerative diseases. Only English articles and those containing the keywords (Withania somnifera AND "neurodegenerative diseases", "neuroprotective effects", "Huntington", "Parkinson", "Alzheimer", "Amyotrophic Lateral Sclerosis", "neurological disorders") in the title or abstract were considered. Reviews, editorials, letters, meta-analyses, conference papers, short surveys, and book chapters were not considered. Selected articles were grouped by pathologies and summarized, considering the mechanism of action. The quality assessment and the risk of bias were performed using the Cochrane Handbook for Systematic Reviews of Interventions checklist. This review uses a systematic approach to summarize the results from 60 investigations to highlight the potential role of W. somnifera and its specialized metabolites in treating or preventing neurodegenerative diseases. [ABSTRACT FROM AUTHOR]

Several foods are used in both the nutraceutical and health sectors; vegetable oils, for example, can prevent the onset of numerous diseases. The properties of these oils are related to their chemical composition and primarily to the presence of fatty acids. The present work aimed to determine the chemical profiles of Argania spinosa, Pinus halepensis, and Pistacia altantica oils, used in traditional Tunisian foods, and to evaluate some biological properties. We evaluated their antioxidant, anti-enzymatic, antimicrobial, and anti-inflammatory properties. Linoleic acid was the main component of the three oils. P. atlantica oil showed more significant inhibitory activity against the enzymes studied than A. spinosa and P. halepensis. All three oils showed similar antioxidant and anti-inflammatory activity. Furthermore, A. spinosa and P. halepensis oils showed antibiofilm activity against P. aeruginosa, with 30–40% inhibition. These results focus on the possible use of these oils in the nutraceutical and healthcare sectors. [ABSTRACT FROM AUTHOR]

Introduction: Aluminum (Al) is a known neurotoxic which is found in air, food and utensils, medicinal preparations, etc., Ficus religiosa (FR) is known as the peepal tree which is worshipped by people at large and has many medicinal importance. The objective of the study is to compare the Al groups of different durations and the treatment groups with FR leaf extract in male Wistar rats. Materials and Methods: In this study, we have taken seven groups of male albino Wistar rats, six in each. Group 1 was normal control group. Groups 2 and 3 were induced groups and Groups 4-7 are treated groups. On the last day of treatment, the brain of the animals was removed, and histology slides were prepared, and viable neurons were counted using software. For behavioral analysis, the passive avoidance test was carried out. Here, the treated Groups 4 and 5 are the groups in which the leaf extract of FR was given after treating with Al for 25 days and for Groups 6 and 7, given after treating with Al for 45 days. The comparison of different durations of the Al groups and treated groups was carried out based on neuronal count in CA3 region of hippocampus. Results: We have observed the neurodegeneration in all regions of hippocampus including dentate gyrus, but mainly, the neurodegeneration was observed in CA3 region of hippocampus. In both the parameters, there was no significant difference observed in terms of change of duration of Al (P > 0.05). The neurodegeneration observed in both Al groups was the same. The effect of treatment was observed a similar improvement in all treated groups even after in change in duration of Al (P > 0.05). Conclusion: Aluminium induced neurodegeneration in rat's brain in both higher and lower duration and in both cases Ficus religiosa treated effectively against neurotoxicity of Al. [ABSTRACT FROM AUTHOR]

Background: RD/M.ph.AA-01 is an Ayurvedic polyherbal formulation, developed for amavata, which is associated with chronic inflammatory autoimmune diseases. Objectives: The study was planned to evaluate the anti-arthritic and anti-inflammatory activity of RD/M.ph.AA-01 in laboratory animals. Materials and Methods: Anti-arthritic activity of RD/M.ph.AA-01 was evaluated at 270 and 405 mg/kg doses against Complete Freund's Adjuvant (CFA)-induced arthritis. Anti-inflammatory activity was studied using cotton pellet granuloma and formalin-induced edema in rat models. The effect of topical application of RD/M.ph.AA-01 on Croton oil ear edema in mice was also investigated. Results: Arthritis induction caused a significant (p<0.05) alteration in paw size, hematology, serum parameters, edematous tissue parameters, lipid peroxidation in the liver and histopathology of joints. These alterations were significantly (p<0.05) prevented by treatment with RD/M.ph.AA-01. In the cotton pellet granuloma, RD/M. ph.AA-01 supplementation caused significant (p<0.05) improvement in the weight of granuloma tissue, serum parameters, lipid peroxidation in the liver and histopathological changes in granuloma tissue. A significant (p<0.05) improvement in paw size, serum parameters and liver lipid peroxidation were observed by RD/M.ph.AA-01 treatment in the formalin-induced edema model. The RD/M.ph.AA-01 also significantly (p<0.05) suppressed Croton oil-induced ear edema. Conclusion: These findings showed that RD/M.ph.AA-01 possesses potent anti-arthritic and anti-inflammatory activity. [ABSTRACT FROM AUTHOR]

Xanthones are natural secondary metabolites that possess great potential as neuroprotective agents due to their prominent biological effects on Alzheimer's disease (AD). However, their underlying mechanisms in AD remain unclear. This study aimed to systematically review the effects and mechanisms of xanthones in cell culture and animal studies, gaining a better understanding of their roles in AD. A comprehensive literature search was conducted in the Medline and Scopus databases using specific keywords to identify relevant articles published up to June 2023. After removing duplicates, all articles were imported into the Rayyan software. The article titles were screened based on predefined inclusion and exclusion criteria. Relevant full-text articles were assessed for biases using the OHAT tool. The results were presented in tables. Xanthones have shown various pharmacological effects towards AD from the 21 preclinical studies included. Cell culture studies demonstrated the anti-cholinesterase activity of xanthones, which protects against the loss of acetylcholine. Xanthones exhibited neuroprotective effects by promoting cell viability, reducing the accumulation of β-amyloid and tau aggregation. The administration of xanthones in animal models resulted in a reduction in neuronal inflammation by decreasing microglial and astrocyte burden. In terms of molecular mechanisms, xanthones prevented neuroinflammation through the modulation of signaling pathways, including TLR4/TAK1/NF-κB and MAPK pathways. Mechanisms such as activation of caspase-3 and -9 and suppression of endoplasmic reticulum stress were also reported. Despite the various neuroprotective effects associated with xanthones, there are limited studies reported on their underlying mechanisms in AD. Further studies are warranted to fully understand their potential roles in AD. [ABSTRACT FROM AUTHOR]

Lantana camara Linn. (Verbenaceae) is used for improving memory in certain African societies. This study investigated the effect of prophylactic treatment with hydroethanolic leaf extract of Lantana camara (LCE) on short-term memory deficit and neuroinflammation induced with scopolamine in zebrafish and mice. Zebrafish (AB strain) and mice (ICR) were given donepezil (0.65 mg/kg, oral) and LCE (10, 30, 100 mg/kg, oral) for 7, and 10 days, respectively, before induction of cognitive impairment with scopolamine immersion (200 µM) and intraperitoneal injection (2 mg/kg), respectively. Spatial short-term memory was assessed in zebrafish using both Y- and T-mazes, whereas Y-maze was used in mice. Mice hippocampal and cortical tissues were analyzed for mRNA expression of proinflammatory genes (IL-1β, IL-6, TNF-α, COX-2) using qRT-PCR. In the zebrafish Y-maze, LCE (10 and 100 mg/kg) increased time spent in the novel arm by 55.89 ± 5.70%, and 68.21 ± 2.75%, respectively, but not at 30 mg/kg. In the zebrafish T-maze, there was an increase in time spent in the food-containing arm at 30 (44.23 ± 2.13) and 100 mg/kg (52.30 ± 1.94). In the mouse Y-maze, spontaneous alternation increased by 52.89 ± 4.98% at only 10 mg/kg. LCE (10, 30, 100 mg/kg) inhibited proinflammatory gene (IL-1β, IL-6, TNF-α, COX-2) mRNA expression, with the highest inhibitory effect on IL-6 in both the hippocampus (83.27 ± 2.49%; 100 mg/kg) and the cortex (98.74 ± 0.11%; 10 mg/kg). LCE ameliorated scopolamine-induced AD in both zebrafish and mice. [ABSTRACT FROM AUTHOR]

Seaweeds have gained interest from the pharmaceutical industry due to their diverse secondary metabolites with potential applications in the prevention and treatment of lifestyle diseases. In spite of the abundance of seaweeds in the coastal area of Iligan Bay in the Philippines, there has been limited investigation into their pharmacological properties. Therefore, this study aimed to evaluate the in vitro α-glucosidase inhibition, angiotensin-converting enzyme (ACE) inhibition, and acetylcholinesterase (AChE) inhibition properties of various fractions obtained from the marine red alga Galaxaura oblongata. The methanol extract of G. oblongata was sequentially partitioned into hexane, dichloromethane, ethyl acetate, butanol, and methanol fractions. All assays were performed in vitro and microplate based. The results of α-glucosidase inhibition activity assay showed that the n-hexane fraction and dichloromethane fraction exhibited greater than 50% inhibitory activity at 200 ppm. Furthermore, ACE inhibition activity assay revealed that dichloromethane fraction, ethyl acetate fraction, and butanol fraction displayed ACE inhibition activity above 50% at 250 ppm. In addition, the hexane fraction, dichloromethane fraction, and ethyl acetate fraction demonstrated potent AChE inhibitory activity at 250 ppm. Overall, the findings show that G. oblongata has antidiabetic, anti-hypertensive, and neuroprotective potentials. This is the first report of the in vitro α-Glucosidase, ACE, and AChE inhibition activities of G. oblongata. Further investigation and purification of the highly potent fractions in each assay is highly suggested to identify and characterize the compounds responsible for the observed bioactivities, which could serve as possible leads for drug discovery efforts in the management of various lifestyle diseases [ABSTRACT FROM AUTHOR]

Fucoxanthin extracted and purified from Vietnamese Sargassum oligocystum Montagne, 1845 exhibits various biological activities. In this study, the ability of fucoxanthin to inhibit acetylcholinesterase (AChE), the antioxidant activities, and the expression of antioxidant enzymes were investigated. Fucoxanthin isolated from Vietnamese S. oligocystum showed no cytotoxic effects; moreover, it exhibited AChE inhibitory activity (with an IC50 value of 130.12 ± 6.65 μg mL−1) and antioxidant activity (with an IC50 value of 3.42 ± 0.15 mg mL−1). At concentrations of 50 and 100 µg mL−1, fucoxanthin provided protection against amyloid β-protein fragment 25–35-induced neurotoxicity in a C6 neuronal cell line, and the survival of C6 cells was higher than 81.01% and 80.98%, respectively, compared to the control group (59%). Moreover, antioxidant enzyme activity and quantitative PCR analysis suggested that the neuroprotective effect of fucoxanthin resulted from regulation of the gene expression of antioxidant enzymes (CAT and GPx) and ER pathways (caspase-3 and Bax), as well as the promotion of expression of genes involved in PI3K/Akt signaling (GSK-3β), autophagy (p62 and ATG5), and the biosynthesis of ACh (VAChT and ChAT). Therefore, fucoxanthin extracted from the seaweed S. oligocystum in Vietnam is a potential feedstock source for the production of health foods that exert neuroprotective effects. [ABSTRACT FROM AUTHOR]

The dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) is considered as an important strategy for the treatment of Alzheimer's disease. In this study, we applied the bioguided fractionations of Ocotea daphinifolia ethyl acetate active extract to furnish a fraction with high inhibitory activity for AChE and BuChE (82% and 92%, respectively). High‐performance liquid chromatography semipreparative purification of this fraction provided two new natural products: 1‐β‐D‐galactopyranosyl‐glycerol‐2,3‐heptanedionate, (1) whose complete chemical structural elucidation was made with spectrometric analysis (MS, 1D, and 2D NMR) and its minor derivative 1‐β‐D‐gulopyranosyl‐glycerol‐2,3‐heptanedionate; (2) which could be characterized by 2D 1H‐13C heteronuclear single‐quantum correlation spectra analysis. Investigation of the intermolecular interactions with cholinesterases was carried out by molecular docking studies, and results suggested that both compounds are capable to interact with the catalytic site of both enzymes. Compounds 1 and 2 interact with residues of catalytic domains and the peripheral anionic binding site of AChE and BuChE. The results are comparable to those achieved with rivastigmine and galantamine. Thus, this study provides evidence for consideration of the glycosylglycerol from O. daphnifolia as new valuable dual cholinesterases inhibitor. [ABSTRACT FROM AUTHOR]

In the present study, the chemical composition and bioactive properties of commercially available Withania somnifera samples were evaluated. The hydromethanolic and aqueous extracts of the tested samples were analyzed in terms of phenolic compound composition, ascorbic acid content, antioxidant and antibacterial activity, and acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities. Polyphenols and ascorbic acid content, as well as the antioxidant activity, were higher in the aqueous extracts than in the hydromethanolic extracts. Generally, aqueous extracts presented higher antioxidant activity than the hydromethanolic ones, especially in the case of 2,2-diphenyl-1-picryl-hydrazyl (DPPH) assay. Moreover, higher amounts of phenolic acids and flavonoids were found in the hydromethanolic extracts compared to the aqueous ones. Regarding the antibacterial properties, samples 4, 6, and 10 showed the best overall performance with growth-inhibitory activities against all the examined bacteria strains. Finally, the aqueous and hydromethanolic extracts were the most efficient extracts in terms of AChE and BChE inhibitory activities, respectively. In conclusion, our results indicate that W. somnifera possesses important bioactive properties which could be attributed to the high amounts of phenolic compounds. However, a great variability was recorded in commercially available products, suggesting significant differences in the origin of product and the processing method. [ABSTRACT FROM AUTHOR]

This work aimed to evaluate the effect of different periods of water restriction supply performed in the preharvest in Cymbopogon nardus, evaluating different conditions of storage in the postharvest. The treatments performed were consisted of four periods of water restriction supply in the plants: 5, 10, 15, and 20 days, and two methods of storage (and preserving) the leaves in the postharvest: 10 days in natural environment (32 ± 2 °C and 75 ± 3% of R.H.) and under cold storage at 0 ± 0.5 °C and 90 ± 2% of R.H. At the final, 18 chemical components have been identified. The main components verified were citronellol (19.3%), at 10 days stored at room temperature, and citronellol (14.1%) and trans-geraniol (55.8%), at 15 days stored at room temperature. In the essential oil, most of the treatments used proved to be effective in inhibiting the enzyme acetylcholinesterase, and fungicidal and bactericidal effects were observed in the minimum inhibitory concentrations of CMIs. The water restriction supply of citronella plants for 10 and 15 days associated with the cold storage of the leaves at 0 °C favored the formation of secondary metabolites. The formation of carotenoids and chlorophyll was superior in the plants subjected to water restriction supply for 10 days (room temperature). For phenolic compounds and antioxidant activity, water restriction supply for 10 days and storage at 0 °C resulted in the highest means, while for flavonoids, water restriction supply for 15 days and storage at 0 °C promoted the best results. [ABSTRACT FROM AUTHOR]

Currently, nearly 36.5 million people live with Alzheimer’s disease worldwide, and acetylcholinesterase inhibition is considered the main treatment strategy against it. Seaweeds (or macroalgae) are a natural source of high-value bioactive compounds and have great potential in the production of health foods/foods, pharmaceuticals, cosmetics, animal feeds, biofertilizers, and biofuels. The most studied and applied seaweed species include red seaweed (Rhodophyta), green seaweed (Chlorophyta) and brown seaweed (Phaeophyta). This study aimed to evaluate the antioxidant and neuroprotective activities of extracts/substances isolated with solvents including ethanol 75° and 96°, water, n-hexane, ethyl acetate under normal and ultrasonic conditions (power 80W, frequency 4.7 kHz and for 1 hour) from 5 economically important seaweed species belonging to genera Caulerpa, Sargassum, Gracilaria, Ulva and Kappaphycus collected in Ninh Thuan and Khanh Hoa provinces, Vietnam. The results have shown that 05/30 extracts and substances (including SaE96S, SaH, SaHW, SaEA and fucosterol) isolated from five seaweed species exhibited high antioxidant activity through the free radical screening method using 2,2-diphenyl-1-picrylhydrazyl (DPPH) (with EC50 values < 5 mg/mL for extracts and EC50 value < 2 mM for substance) in comparison with positive control ascorbic acid (EC50 = 0.015 mg/mL); acetylcholinesterase inhibitory activity using acetylcholinesterase inhibitor screening KIT (with IC50 values of < 200 μg/mL for both extracts and substances), compared with positive control galantamine (with IC50 value of 52,8 μg/mL). The extracts/substances were able to protect the cell against cytotoxity in the C6 alzheimer’s disease cell model induced by amyloid beta-protein fragment (Aβ25-35). The results achieved from this research have proven that the extracts/substances isolated from seaweed species were a potential source of medicinal agents for the prevention and treatment of alzheimer’s disease. [ABSTRACT FROM AUTHOR]

Ficus religiosa (Bo tree or sacred fig) and Ficus benghalensis (Indian banyan) are of immense spiritual and therapeutic importance. Various parts of these trees have been investigated for their antioxidant, antimicrobial, anticonvulsant, antidiabetic, anti-inflammatory, analgesic, hepatoprotective, dermoprotective, and nephroprotective properties. Previous reviews of Ficus mostly discussed traditional usages, photochemistry, and pharmacological activities, though comprehensive reviews of the neuroprotective potential of these Ficus species extracts and/or their important phytocompounds are lacking. The interesting phytocompounds from these trees include many bengalenosides, carotenoids, flavonoids (leucopelargonidin-3-O-β-d-glucopyranoside, leucopelargonidin-3-O-α-l-rhamnopyranoside, lupeol, cetyl behenate, and α-amyrin acetate), flavonols (kaempferol, quercetin, myricetin), leucocyanidin, phytosterols (bergapten, bergaptol, lanosterol, β-sitosterol, stigmasterol), terpenes (α-thujene, α-pinene, β-pinene, α-terpinene, limonene, β-ocimene, β-bourbonene, β-caryophyllene, α-trans-bergamotene, α-copaene, aromadendrene, α-humulene, alloaromadendrene, germacrene, γ-cadinene, and δ-cadinene), and diverse polyphenols (tannin, wax, saponin, leucoanthocyanin), contributing significantly to their pharmacological effects, ranging from antimicrobial action to neuroprotection. This review presents extensive mechanistic insights into the neuroprotective potential, especially important phytochemicals from F. religiosa and F. benghalensis. Owing to the complex pathophysiology of neurodegenerative disorders (NDDs), the currently existing drugs merely alleviate the symptoms. Hence, bioactive compounds with potent neuroprotective effects through a multitarget approach would be of great interest in developing pharmacophores for the treatment of NDDs. [ABSTRACT FROM AUTHOR]

The mosquito vectors of the genera Aedes and Anopheles present resistance to several commercial insecticides, which are also toxic to non-predator targets. On the other hand, essential oils are a promising source of insecticides. Thus, in this work, the essential oil from the leaves of Piper purusanum was characterized by gas chromatography–based approaches and evaluated as biodefensive against malaria and dengue vectors. The main compounds of P. purusanum essential oil were β-caryophyllene (57.05%), α-humulene (14.50%), and germacrene D (8.20%). The essential oil inhibited egg hatching (7.6 ± 1.5 to 95.6 ± 4.5%), caused larval death (LC50 from 49.84 to 51.60 ppm), and inhibited the action of acetylcholinesterase (IC50 of 2.29 µg/mL), which can be related to the mechanisms of action. On the other hand, the biological activities of β-caryophyllene, α-humulene, and germacrene D were higher than that of essential oil. In addition, these sesquiterpenes and essential oil did not show a lethal effect on Toxorhynchites splendens, Anisops bouvieri, Gambusia affinis, and Diplonychus indicus (LC50 from 2098.80 to 7707.13 ppm), although D. indicus is more sensitive (SI/PSF from 48.56 to 252.02 ppm) to essential oil, representing a natural alternative against these relevant vectors. [ABSTRACT FROM AUTHOR]

Background: Cognitive health is of great interest to society, with neuroinflammation and systemic inflammation age-related risk factors that are linked to declines in cognitive performance. Several botanical ingredients have been suggested to have benefits in this area including Salvia officinalis (sage), which has shown anti-inflammatory effects and exhibited promising cognitive improvements in multiple human studies. The current study demonstrates anti-inflammatory effects for S. officinalis across a broad set of in vitro models in human cells, and adds further evidence to support modulation of acetylcholine and monoamine neurostransmitter levels as mechanisms that contribute towards the benefits of the herb on cognitive health. Methods: The effect of S. officinalis extract on release of multiple cytokines and chemokines was measured in human primary intestinal epithelial cells treated with or without LPS stimulation, and Blood Brain Barrier (BBB) cells in presence or absence of recombinant IL-17A and/or Human IL-17RA/IL-17R Antibody. Antioxidant effects were also assessed in BBB cells incubated with the extract and H2O2. The anti-inflammatory effects of S. officinalis extract were further assessed based on clinically-relevant biomarker readouts across 12 human primary cell-based disease models of the BioMAP Diversity PLUS panel. Results: S. officinalis showed significant attenuation of the release of most cytokines/chemokines into apical media in LPS-stimulated intestinal cells, but small increases in the release of markers including IL-6, IL-8 in basolateral media; where TNF-α was the only marker to be significantly reduced. S. officinalis attenuated the release of CRP and VCAM-1 from BBB cells under IL-17A induced conditions, and also decreased H2O2 induced ROS overproduction in these cells. Phenotypic profiling with the BioMAP Diversity PLUS Panel identified additional anti-inflammatory mediators, and based on a similarity search analysis suggested potential mechanistic similarity to caffeic acid and drugs known to inhibit COMT and MAO activity to modulate monoamine metabolism. Subsequent in vitro assessment showed that S. officinalis was able to inhibit the activity of these same enzymes. Conclusions: S. officinalis extract showed anti-inflammatory effects across multiple human cell lines, which could potentially reduce peripheral inflammation and support cognitive health. S. officinalis extract also showed the ability to inhibit enzymes related to the metabolism of monoamine neurotransmitters, suggesting possible dopaminergic and serotonergic effects acting alongside proposed cholinergic effects to mediate acute cognitive performance benefits previously demonstrated for the extract. [ABSTRACT FROM AUTHOR]

Alzheimer's disease (AD) is a progressive neurological illness with few effective treatments. Thus, ameliorating the effects of AD using natural products has attracted global attention with promising efficacy and safety. In this study, ten tropical fruits including Ananas comosus 'Phulae', Ananas comosus 'Pattavia', Carica papaya 'Khaekdum', Carica papaya 'Khaeknuan', Durio zibethinus 'Monthong', Durio zibethinus 'Chanee', Psidium guajava 'Kimju', Psidium guajava 'Keenok', Mangifera indica 'Kaew' and Mangifera indica 'Namdokmai' were screened for their inhibitory activities against the key enzymes, cholinesterases and β-secretase (BACE-1), involved in AD pathogenesis. The top three fruit extracts with promising in vitro anti-AD activities were further investigated using rat pheochromocytoma PC-12 neuronal cell line and Drosophila AD model. Data showed that M. indica 'Kaew', M. indica 'Namdokmai' and P. guajava 'Kimju' reduced Aβ1–42-mediated neurotoxicity by promoting glutathione-dependent enzymes, while M. indica 'Namdokmai' limited Aβ1–42 peptide formation via BACE-1 inhibition and amended locomotory behavior of the Drosophila AD model. Results indicated the potential anti-AD properties of tropical fruits, particularly M. indica 'Namdokmai' in the prevention of Aβ1–42-mediated neurotoxicity and as a BACE-1 blocker. [ABSTRACT FROM AUTHOR]

Semecarpus anacardium Linn. a potent ethanomedicinal plant belonging to Family-Anacardiaceae, commonly known as 'Bhallatak' or 'Bhilawa'. It has potent medicinal value in Ayurveda and siddha system of medicine. Bhilawa is being used traditionally and ethanobotanically for several treatments. Phytochemical analysis of Semecarpus anacardium nut shows biologically active compounds such as biflavonoids, phenolic compounds, bhilawanols, minerals, vitamins and amino acids, which shows various medicinal properties. Traditional healers and physicians use formulations of Semecarpus anacardium in their clinical practice. In market there are number of formulations among them commonly used formulations are Amritbhallatak Avaleha, Bhallatakasav, Suran vatak, Bhallatak Parpati, Sanjeevani Vati, Narsimha choorna, etc. Several experiments have proved pharmacological activities of Semecarpus anacardium as anti-atherogenic, antioxidant, anti-inflammatory, hypoglycemic, antimicrobial, anti-reproductive, CNS stimulant, anticarcinogenic and hair growth promoter activities. [ABSTRACT FROM AUTHOR]

In this study, monofloral honeys (chaste, thyme, citrus, and heather) which were obtained from different sources from members of Beekeeping Associations in South-West Anatolia were studied for their antioxidant capacity, total phenolic amounts, total flavonoid amounts, acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and urease inhibition activities. Antioxidant capacity of honey samples was determined by ß-carotene, DPPH, ABTS+ and CUPRAC activity methods. In honey samples, the highest antioxidant activity was found in citrus honey with ß-carotene/Linoleic acid color opening with IC50: 7.99 mg/mL, and DPPH free radical removal activity with IC50: 5.28 mg/mL in thyme honey. In CUPRAC activity, it was determined that the highest activity was found in heather honey with IC50: 1.69 mg/mL, in terms of ABTS+ removal activity IC50: 2.80 mg/mL in chaste honey, and metal chelating activity IC50: 1.56 mg/mL in thyme honey. The total phenolic and flavonoids amounts of honeys ranged from 2.31 and 27.15 (µg PEs/mg) to 4.95 and 25.24 (µg QEs/mg), respectively. In addition, AChE inhibition IC50: 24.25 mg/mL in thyme honey, BChE inhibition IC50: 27.93 mg/mL in thyme honey, and urease inhibition IC50: 34.89 mg/mL with citrus honey were determined concerning the highest activity, consecutively. [ABSTRACT FROM AUTHOR]

Bryophyllum pinnatum (Lam.) Oken (Crassulaceae) is used traditionally to treat many ailments. This study characterizes the constituents of B. pinnatum flavonoid-rich fraction (BPFRF) and investigates their antioxidant and anticholinesterase activity using in vitro and in silico approaches. Methanol extract of B. pinnatum leaves was partitioned to yield the ethyl acetate fraction. BPFRF was isolated from the ethyl acetate fraction and purified. The constituent flavonoids were structurally characterized using UPLC-PDA-MS2. Antioxidant activity (DPPH), Fe2+-induced lipid peroxidation (LP) and anticholinesterase activity (Ellman's method) of the BPFRF and standards (ascorbic acid and rivastigmine) across a concentration range of 3.125–100 μg/mL were evaluated in vitro for 4 months. Molecular docking was performed to give insight into the binding potentials of BPFRF constituents against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). UPLC-PDA-MS2 analysis of BPFRF identified carlinoside, quercetin (most dominant), luteolin, isorhamnetin, luteolin-7-glucoside. Carlinoside was first reported in this plant. BPFRF significantly inhibited DPPH radical (IC50 = 7.382 ± 0.79 µg/mL) and LP (IC50 = 7.182 ± 0.60 µg/mL) better than quercetin and ascorbic acid. Also, BPFRF exhibited potent inhibition against AChE and BuChE with IC50 values of 22.283 ± 0.27 µg/mL and 33.437 ± 1.46 µg/mL, respectively compared to quercetin and rivastigmine. Docking studies revealed that luteolin-7-glucoside, carlinoside and quercetin interact effectively with crucial amino acid residues of AChE and BuChE through hydrogen bonds. BPFRF possesses an excellent natural source of cholinesterase inhibitor and antioxidant. The material could be further explored for the potential treatment of oxidative damage and cholinergic dysfunction in Alzheimer's disease. [ABSTRACT FROM AUTHOR]